Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05652751
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Registry
-
NCT05652751
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05652751. Randomized; triple masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2023-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of EA Combined With NGF on Limb Function in Convalescent Patients With Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- nerve growth factor
- Intervention (Drug)
- physiological saline
- Intervention (Device)
- EA
- Intervention (Device)
- sham EA
- Lead sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University
Record details
- Record id
cardio:ct-nct05652751- Content hash
22a9488b9632a3386bce7d4257d28b921d99447dc7d735e62ae7d5b4fa779457